Sort   by:  
 Page size 
Trastuzumab improves survival outcomes in patients with HER2+ metastatic breast cancer. Some of these patients may become long-term survivors. The Long-Her study was designed to identify clinical and molecular markers that could differentiate long-term survivors from patients having early progressio...
ORGANISM(S): Homo sapiens 
Sort   by:  
 Page size